Evaluation of Optimal Treatment With Bevacizumab in Patients With Platinum-sensitive Recurrent Ovarian Cancer - Scottish Gyn Cancer Study Group Ovarian Cancer and Us OVARIAN CANCER and US Ovarian Cancer and Us

Blog Archives: Nov 2004 - present

#ovariancancers



Special items: Ovarian Cancer and Us blog best viewed in Firefox

Search This Blog

Tuesday, April 23, 2013

Evaluation of Optimal Treatment With Bevacizumab in Patients With Platinum-sensitive Recurrent Ovarian Cancer - Scottish Gyn Cancer Study Group



Full Text View - ClinicalTrials.gov

This study is not yet open for participant recruitment.
Verified April 2013 by AGO Research GmbH
Sponsor:
Collaborators:
Arbeitsgemeinschaft Gynaekologische Onkologie Austria
ARCAGY/ GINECO GROUP
ANZGOG
Scottish Gynaecological Cancer Study Group
Information provided by (Responsible Party):
AGO Research GmbH
Blogger

0 comments :

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments ( Atom )